BTLA antibodies

MYPI2025005290A0Undetermined Publication Date: 2021-12-11OXFORD UNIVERSITY INNOVATION LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025005290
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-06-11
Filing Date
2021-06-11
Publication Date
2021-12-11
Patent Text Reader

Abstract

This invention relates generally to antibodies that bind to human B and T lymphocyte attenuator (BTLA) and uses thereof. More specifically, the invention relates to agonistic antibodies that bind human BTLA and modulate its activity, and their use in treating inflammatory, autoimmune and proliferative diseases and disorders. Suitably, the antibodies also possess an Fc modification that enhances signalling through FcɣR2B.
Need to check novelty before this filing date? Find Prior Art